INDEGENE
Back to All Ratios
|
INDEGENE Last 5 Year EV/CE History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/CE(x) | 5.15 | 0.14 | 0.24 | -0.64 | -0.33 |
What is the latest EV/CE ratio of INDEGENE ?
Year | EV/CE |
---|---|
Mar2025 | 5.15 |
Mar2024 | 0.14 |
Mar2023 | 0.24 |
Mar2022 | -0.64 |
Mar2021 | -0.33 |
How is EV/CE of INDEGENE Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2025 | 5.15 | 3,578.57 | |
Mar2024 | 0.14 | -41.67 | |
Mar2023 | 0.24 | Positive | |
Mar2022 | -0.64 | Negative | |
Mar2021 | -0.33 | - |
Other Financial Ratios of INDEGENE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,271.5 Cr | 0.1% | -4.1% | -6.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.4% | -3% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,886.0 Cr | 0.6% | -3.1% | 20.2% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | 0% | 5.2% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 0.8% | -1.9% | 2.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | 0.1% | 3.5% | -10.6% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 0.1% |
-4.1% |
-6.3% |
SENSEX | -0.3% |
-0.8% |
-1.9% |
You may also like the below Video Courses